The ‘genetic hack’ was accelerated past the animal testing stage and will be used on healthy volunteers, then patients if it deemed safe.
It comes as scientists in Britain said a vaccine could be tested on humans by June after encouraging results on mice.
Massachusetts-based Moderna created the candidate cure but have taken a different route to traditional techniques.
Normally a weaker bug is planted in the body so a patient can adapt to fight off the infection.
But the new method sees messenger RNA stimulates the immune system to make similar proteins to the killer virus, which it can then combat.